Details for New Drug Application (NDA): 085373
✉ Email this page to a colleague
NDA 085373 describes HYDROCHLOROTHIAZIDE W/ HYDRALAZINE, which is a drug marketed by Watson Labs and is included in one NDA. Additional details are available on the HYDROCHLOROTHIAZIDE W/ HYDRALAZINE profile page.
The generic ingredient in HYDROCHLOROTHIAZIDE W/ HYDRALAZINE is hydralazine hydrochloride; hydrochlorothiazide. There are twenty-one drug master file entries for this compound. Additional details are available on the hydralazine hydrochloride; hydrochlorothiazide profile page.
The generic ingredient in HYDROCHLOROTHIAZIDE W/ HYDRALAZINE is hydralazine hydrochloride; hydrochlorothiazide. There are twenty-one drug master file entries for this compound. Additional details are available on the hydralazine hydrochloride; hydrochlorothiazide profile page.
Summary for 085373
| Tradename: | HYDROCHLOROTHIAZIDE W/ HYDRALAZINE |
| Applicant: | Watson Labs |
| Ingredient: | hydralazine hydrochloride; hydrochlorothiazide |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 25MG;15MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
